HealthStream (NASDAQ:HSTM) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

HealthStream (NASDAQ:HSTM) announced its quarterly earnings results on Monday. The technology company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.16 by $0.02, FiscalAI reports. HealthStream had a net margin of 6.60% and a return on equity of 6.81%. The company had revenue of $83.31 million for the quarter, compared to analyst estimates of $82.24 million.

HealthStream Stock Performance

HealthStream stock traded up $0.88 during trading on Monday, reaching $34.58. 281,916 shares of the company’s stock were exchanged, compared to its average volume of 250,824. HealthStream has a 52-week low of $19.50 and a 52-week high of $35.60. The firm has a market cap of $1.01 billion, a price-to-earnings ratio of 48.03, a PEG ratio of 3.90 and a beta of 0.45. The company’s 50-day moving average is $30.94 and its two-hundred day moving average is $25.59.

Insider Activity at HealthStream

In other news, Director Linda Rebrovick sold 12,000 shares of the company’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $35.00, for a total value of $420,000.00. Following the completion of the transaction, the director directly owned 39,329 shares in the company, valued at approximately $1,376,515. This represents a 23.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Robert Frist, Jr. sold 144,068 shares of the firm’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $29.50, for a total value of $4,250,006.00. Following the sale, the chief executive officer owned 3,907,038 shares of the company’s stock, valued at $115,257,621. This represents a 3.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 20.40% of the company’s stock.

Wall Street Analysts Forecast Growth

HSTM has been the topic of several analyst reports. Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday. Canaccord Genuity Group lifted their price target on shares of HealthStream from $24.00 to $27.00 and gave the company a “hold” rating in a research report on Tuesday, July 21st. Freedom Capital upgraded shares of HealthStream to a “hold” rating in a report on Tuesday, October 13th. Citigroup restated a “market perform” rating on shares of HealthStream in a research report on Tuesday, October 27th. Finally, Weiss Ratings raised shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $27.00.

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.